PERISCOPE
Live / Applied — First extension granted (statement of use) (as of 17 Oct 2025)
What this means for you
Not registered yet, but its 26 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97907734
- Mark type
- Stylized text
- Filed
- 26 Apr 2023
- Published for opposition
- 05 Nov 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and therapeutic preparations for medical purposes for the treatment of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, and fungal diseases and disorders
- Class 042 — Scientific and technological services: Providing online, non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of healthcare, wellness, system dysregulation, disease, biomedical, and genomic research; Providing online, non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, scientific research and analysis in the field of design and characterization of biologic therapeutic products
Owner
- ETIOME, INC., CAMBRIDGE, MA, US
- ETIOME, INC., CAMBRIDGE, MA, US
- Flagship Labs 84, Inc., Cambridge, MA, US
Prosecution history
- 18 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Oct 2025 — SOU EXTENSION 1 GRANTED
- 17 Oct 2025 — SOU EXTENSION 1 FILED
- 17 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Mar 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 03 Feb 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 03 Feb 2025 — ASSIGNED TO PETITION STAFF
- 31 Dec 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 25 Nov 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED